Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy

Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy

We evaluated the efficacy of gemcitabine-cisplatin (GC) therapy as a second line chemotherapy for recurrent urothelial cancer previously treated with or resistant to methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) therapy. Four patients who had recurrent cancer after adjuvant M-VAC ther...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 52(2006), 9 vom: 02. Sept., Seite 693-8; discussion 698
Auteur principal: Honda, Masahito (Auteur)
Autres auteurs: Hatano, Koji, Satoh, Mototaka, Tsujimoto, Yuichi, Takada, Tsuyoshi, Matsumiya, Kiyomi, Fujioka, Hideki
Format: Article
Langue:Japanese
Publié: 2006
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Deoxycytidine 0W860991D6 Vinblastine 5V9KLZ54CY Doxorubicin 80168379AG Cisplatin Q20Q21Q62J plus... Methotrexate YL5FZ2Y5U1 Gemcitabine